The veteran's astrocytoma and cerebrovascular accident (CVA) were granted service connection, with the CVA being secondary to the astrocytoma.
The deciding factor: The evidence supports a finding that the astrocytoma is related to Agent Orange exposure, and the CVA was caused by treatment for the astrocytoma.
- Claimed conditions
- Astrocytoma, Cerebrovascular Accident (CVA)
- How they argued it
- Presumptive (no nexus needed)
- Exposure basis
- Agent Orange / herbicides
- Rating assigned
- 100%
- Decision date
- March 25, 2008
- Citation
- 0809857
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Dismissed
The appeal for a higher disability rating of PTSD from April 19, 2017 is dismissed. The claim for service connection of CVA secondary to hypertension is remanded.
- Remanded (sent back)
The Board has decided to remand the case due to the need for a new medical opinion regarding the Veteran's Cerebrovascular Accident (CVA) and whether it required aid and attendance.
- Granted
The veteran's death was caused by pneumonia due to a cerebrovascular accident (CVA) as a result of coronary artery disease (CAD). The VA medical treatment from January to March 2000 did not cause or contribute substantially to the veteran's death.
- Remanded (sent back)
The Board remands the claim for a medical opinion addressing whether the Veteran's left eye condition is related to service, as it found that the condition did not preexist service.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.